Commonwealth of Pennsylvania Public School Employees Retirement System’s PTC Therapeutics PTCT Stock Holding History

Commonwealth of Pennsylvania Public School Employees Retirement System’s Portfolio PTCT Stock Details PTCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.6M	Sell	19,670 -185	-0.9%	-$13.4K	0.01%	954
2026 Q1	$1.35M	Sell	19,855 -22	-0.1%	-$1.56K	0.01%	981
2025 Q4	$1.51M	Buy	+19,877	New	+$1.44M	0.01%	931

Other funds holding PTCT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Commonwealth of Pennsylvania Public School Employees Retirement System's PTCT Position: Q2 2026 in Review

Commonwealth of Pennsylvania Public School Employees Retirement System reduced its PTC Therapeutics (PTCT) stake by 0.93% in Q2 2026, selling an estimated $13.4K and leaving 19,670 shares worth $1.6M. The position accounts for 0.01% of the portfolio, ranked #954.

Commonwealth of Pennsylvania Public School Employees Retirement System first reported a position in PTCT in Q4 2025 and has held it in 3 quarters since. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

Commonwealth of Pennsylvania Public School Employees Retirement System held 19,670 shares of PTC Therapeutics worth $1.6M as of Q2 2026.
Commonwealth of Pennsylvania Public School Employees Retirement System sold 185 PTC Therapeutics shares in Q2 2026, an estimated $13.4K.
PTC Therapeutics made up 0.01% of Commonwealth of Pennsylvania Public School Employees Retirement System's portfolio in Q2 2026, its #954 holding.
Commonwealth of Pennsylvania Public School Employees Retirement System first reported a position in PTC Therapeutics in Q4 2025 and has held it in 3 quarters since.
382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Commonwealth of Pennsylvania Public School Employees Retirement System's 13F filing for Q2 2026, filed 17 Jul 2026.